These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 16026280)

  • 1. Antiphospholipid syndrome: characteristics and obstetrical management.
    Nishiguchi T; Kobayashi T
    Curr Drug Targets; 2005 Aug; 6(5):593-605. PubMed ID: 16026280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis and management of the antiphospholipid syndrome.
    Chaturvedi S; McCrae KR
    Blood Rev; 2017 Nov; 31(6):406-417. PubMed ID: 28784423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Managing antiphospholipid syndrome in pregnancy.
    Schreiber K; Hunt BJ
    Thromb Res; 2019 Sep; 181 Suppl 1():S41-S46. PubMed ID: 31477227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous immunoglobulins and antiphospholipid syndrome: How, when and why? A review of the literature.
    Tenti S; Cheleschi S; Guidelli GM; Galeazzi M; Fioravanti A
    Autoimmun Rev; 2016 Mar; 15(3):226-35. PubMed ID: 26656906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiphospholipid antibody profile based obstetric outcomes of primary antiphospholipid syndrome: the PREGNANTS study.
    Saccone G; Berghella V; Maruotti GM; Ghi T; Rizzo G; Simonazzi G; Rizzo N; Facchinetti F; Dall'Asta A; Visentin S; Sarno L; Xodo S; Bernabini D; Monari F; Roman A; Eke AC; Hoxha A; Ruffatti A; Schuit E; Martinelli P;
    Am J Obstet Gynecol; 2017 May; 216(5):525.e1-525.e12. PubMed ID: 28153662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiphospholipid antibody syndrome.
    Kutteh WH; Hinote CD
    Obstet Gynecol Clin North Am; 2014 Mar; 41(1):113-32. PubMed ID: 24491987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiphospholipid syndrome: An update on risk factors for pregnancy outcome.
    De Carolis S; Tabacco S; Rizzo F; Giannini A; Botta A; Salvi S; Garufi C; Benedetti Panici P; Lanzone A
    Autoimmun Rev; 2018 Oct; 17(10):956-966. PubMed ID: 30118899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and management of non-criteria obstetric antiphospholipid syndrome.
    Arachchillage DR; Machin SJ; Mackie IJ; Cohen H
    Thromb Haemost; 2015 Jan; 113(1):13-9. PubMed ID: 25318976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antiphospholipid syndrome: still an enigma.
    Chaturvedi S; McCrae KR
    Hematology Am Soc Hematol Educ Program; 2015; 2015():53-60. PubMed ID: 26637701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obstetric antiphospholipid syndrome: an update on pathophysiology and management.
    Ernest JM; Marshburn PB; Kutteh WH
    Semin Reprod Med; 2011 Nov; 29(6):522-39. PubMed ID: 22161465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hydroxychloroquine to obtain pregnancy without adverse obstetrical events in primary antiphospholipid syndrome: French phase II multicenter randomized trial, HYDROSAPL].
    Mekinian A; Vicaut E; Cohen J; Bornes M; Kayem G; Fain O
    Gynecol Obstet Fertil Senol; 2018; 46(7-8):598-604. PubMed ID: 30041771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of maternal antiphospholipid syndrome.
    Fernandes MA; Gerardi MC; Andreoli L; Tincani A
    Clin Exp Rheumatol; 2020; 38(1):149-156. PubMed ID: 31287415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
    Arnout J
    Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and management of obstetrical antiphospholipid syndrome: where do we stand?
    Marchetti T; Cohen M; Gris JC; de Moerloose P
    Pol Arch Med Wewn; 2013; 123(12):713-20. PubMed ID: 24382555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on the current recommendations and outcomes in pregnant women with antiphospholipid syndrome.
    Chighizola CB; Gerosa M; Trespidi L; Di Giacomo A; Rossi F; Acaia B; Meroni PL
    Expert Rev Clin Immunol; 2014 Nov; 10(11):1505-17. PubMed ID: 25300673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refractory obstetrical antiphospholipid syndrome: Features, treatment and outcome in a European multicenter retrospective study.
    Mekinian A; Alijotas-Reig J; Carrat F; Costedoat-Chalumeau N; Ruffatti A; Lazzaroni MG; Tabacco S; Maina A; Masseau A; Morel N; Esteve-Valverde EE; Ferrer-Oliveras R; Andreoli L; De Carolis S; Josselin-Mahr L; Abisror N; Nicaise-Roland P; Tincani A; Fain O;
    Autoimmun Rev; 2017 Jul; 16(7):730-734. PubMed ID: 28478081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous immunoglobulin therapy of antiphospholipid syndrome.
    Sherer Y; Levy Y; Shoenfeld Y
    Rheumatology (Oxford); 2000 Apr; 39(4):421-6. PubMed ID: 10817776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of pregnancy complications and treatment in obstetric antiphospholipid syndrome in China.
    Zhou Z; Teng J; Sun Y; Liu H; Cheng X; Su Y; Yang C; Ye J
    Clin Rheumatol; 2019 Nov; 38(11):3161-3168. PubMed ID: 31290022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current insights in obstetric antiphospholipid syndrome.
    Schreiber K; Radin M; Sciascia S
    Curr Opin Obstet Gynecol; 2017 Dec; 29(6):397-403. PubMed ID: 28915160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.